| Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma TP Radon, NJ Massat, R Jones, W Alrawashdeh, L Dumartin, D Ennis, ... Clinical Cancer Research 21 (15), 3512-3521, 2015 | 204 | 2015 |
| AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D L Dumartin, HJ Whiteman, ME Weeks, D Hariharan, B Dmitrovic, ... Cancer research 71 (22), 7091-7102, 2011 | 158 | 2011 |
| Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells L Dumartin, C Quemener, H Laklai, J Herbert, R Bicknell, C Bousquet, ... Gastroenterology 138 (4), 1595-1606. e8, 2010 | 137 | 2010 |
| A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma S Haider, J Wang, A Nagano, A Desai, P Arumugam, L Dumartin, ... Genome medicine 6, 1-11, 2014 | 125 | 2014 |
| ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation L Dumartin, W Alrawashdeh, SM Trabulo, TP Radon, K Steiger, ... Oncogene 36 (22), 3094-3103, 2017 | 92 | 2017 |
| Splice variants as novel targets in pancreatic ductal adenocarcinoma J Wang, L Dumartin, A Mafficini, P Ulug, A Sangaralingam, NA Alamiry, ... Scientific reports 7 (1), 2980, 2017 | 55 | 2017 |
| Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer H Laklai, S Laval, L Dumartin, P Rochaix, M Hagedorn, A Bikfalvi, ... Proceedings of the National Academy of Sciences 106 (42), 17769-17774, 2009 | 55 | 2009 |
| Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling W Alrawashdeh, R Jones, L Dumartin, TP Radon, PR Cutillas, ... Molecular Oncology 13 (5), 1075-1091, 2019 | 46 | 2019 |
| Dual roles for CXCL4 chemokines and CXCR3 in angiogenesis and invasion of pancreatic cancer C Quemener, J Baud, K Boyé, A Dubrac, C Billottet, F Soulet, F Darlot, ... Cancer research 76 (22), 6507-6519, 2016 | 37 | 2016 |
| AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting AY Liu, AD Kanan, TP Radon, S Shah, ME Weeks, JM Foster, ... Oncotarget 10 (42), 4276, 2019 | 16 | 2019 |
| From development to cancer-an ever-increasing role of AGR2 D Jach, Y Cheng, F Prica, L Dumartin, T Crnogorac-Jurcevic American journal of cancer research 11 (11), 5249, 2021 | 13 | 2021 |
| CXCL4L1 como biomarcador de cáncer pancreático A Bikfalvi, H Prats, A Dubrac, M Hagedorn, L Dumartin | | 2014 |
| Cxcl4l1 as a biomarker of pancreatic cancer A Bikfalvi, H Prats, A Dubrac, M Hagedorn US Patent App. 13/131,084, 2011 | | 2011 |
| Cxcl4l1 as a biomarker of pancreatic cancer A Bikfalvi, H Prats, A Dubrac, M Hagedorn, L Dumartin | | 2010 |
Tatjana Crnogorac-JurcevicAssociate Professor, Barts Cancer Institute, QMULVerified email at qmul.ac.uk
